Asakowicz Steve 4
4 · HESKA CORP · Filed Mar 9, 2018
Insider Transaction Report
Form 4
HESKA CORPHSKA
Asakowicz Steve
EVP, Comp. Animal Health Sales
Transactions
- Award
Incentive Stock Option (right to buy)
2018-03-07+1,433→ 1,433 totalExercise: $69.77Exp: 2028-03-06→ Common Stock (1,433 underlying) - Award
Non-Qualified Stock Option (right to buy)
2018-03-07+8,567→ 8,567 totalExercise: $69.77Exp: 2028-03-06→ Common Stock (8,567 underlying) - Award
Performance Shares
2018-03-07+1,970→ 1,970 totalExp: 2025-03-31→ Common Stock (1,970 underlying)
Footnotes (2)
- [F1]The aggregate of these two option awards vests in three approximately equal annual installments beginning on March 7, 2019 and ending on March 7, 2021.
- [F2]The vesting of each of three approximately equal performance share tranches is contingent on the achievement of certain market-vesting thresholds based on the price per share of Heska's common stock average over a 20-day trailing trading period. The first tranche is to vest at the later of the achievement of $87.21 per share or the second anniversary of grant date. The second tranche is to vest at the later of the achievement of $101.17 per share or the third anniversary of grant date. The third tranche is to vest at the later of the achievement of $122.10 per share or the fourth anniversary of grant date. Any performance shares that do not vest by March 31, 2025 are to be forfeited.